|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Future technology-enabled care for diabetes and hyperglycemia in the hospital setting显示文摘Patients with diabetes are increasingly common in hospital settings where optimal glycemic control remains challenging.Inpatient technology-enabled support systems are being designed,adapted and evaluated to meet this challenge.Insulin pump use,increasingly common in outpatients,has been shown to be safe among select inpatients.Dedicated pump protocols and provider training are needed to optimize pump use in the hospital.Continuous glucose monitoring(CGM)has been shown to be comparable to usual care for blood glucose surveillance in intensive care unit(ICU)settings but data on cost effectiveness is lacking.CGM use in non-ICU settings remains investigational and patient use of home CGM in inpatient settings is not recommended due to safety concerns.Compared to unstructured insulin prescription,a continuum of effective electronic medical record-based support for insulin prescription exists from passive order sets to clinical decision support to fully automated electronic Glycemic Management Systems.Relative efficacy and cost among these systems remains unanswered.An array of novel platforms are being evaluated to engage patients in technology-enabled diabetes education in the hospital.These hold tremendous promise in affording universal access to hospitalized patients with diabetes to effective self-management education and its attendant short/long term clinical benefits. | Alex Renato Montero Jeffrey S Dubin Paul Sack Michelle F Magee | 2019 | World Journal of Diabetes2019，10，9： | 2 |
| 2 | Bronchoalveolar macrophage CD14 expression: shift between membrane-associated and soluble pools显示文摘 | Hasday R D Dubin W Mongovin S | 1997 | Am J Physiol1997，272，51： | 2 |
| 3 | The development of fear of falling among community-living older women:predisposing factors and subsequent fall events显示文摘 | Murphy S Dubin J Gill T | 2003 | A Biol Sci Med Sci2003，58，10： | 1 |
| 4 | Effect of obesity on safe duration of apnea in anesthetized humans显示文摘 | Jense H C Dubin S A Silverstein P I | 1991 | Anesthesia & Analgesia1991，72，1： | 1 |
| 5 | Arrhythmogenic forms of heart failure in children 显示文摘 | Berger S Dubin AM | 2010 | Heart Fail C1in2010，6，4： | 1 |
| 6 | Arrhythmogenic forms of heart failure in children 显示文摘 | Berger S Dubin AM | 2010 | Heart Failure Clin2010，6，4： | 1 |
| 7 | Laser scribing ofhigh-performance and flexible graphene-based electrochemical capacitors显示文摘 | EL-KADY M F STRONG V DUBIN S | 2012 | Science2012，335，6074： | 1 |
| 8 | Carboxlated starburst dendrimers as calibration standards for agucous size exclusion chromatography显示文摘 | MEHTA M S TOMALIA D T | 1992 | Anal Chem1992，64，20： | 1 |
| 9 | Impact of positive end-expiratory pressure on the definition of acute respiratory distress syndrome显示文摘 | Elisa Estenssoro Arnaldo Dubin Enrique Laffaire Héctor S Canales Gabriela Sáenz Miriam Moseinco Pierina Bachetti | 2003 | Intensive Care Medicine2003，，11： | 1 |
| 10 | Postoperative packing after septoplasty: is it necessary? 显示文摘 | DUBIN M R PLETCHER S D | 2009 | Otolaryngol Clin North Am2009，42，2： | 1 |
| 11 | Prevalence of macrolids-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci显示文摘 | Jenssen WD Thakker Varia S Dubin DT | 1987 | Antimicrob Agent Chemother1987，31，： | 1 |
| 12 | Effect of obesity on safe duration of apnea in anesthetized humans显示文摘 | Jense H G Dubin S A Silverstein P I | 1991 | Anesth Analg1991，72，1： | 1 |
| 13 | Molecular analysis of the tk locus in L5178Y large and small colony mouse lymphoma cell mutants induced by hycanthone methanesulfonate显示文摘 | EL-TARRAS A DUBINS J S WARNER J | 1995 | Mutat Res1995，332，12： | 1 |
| 14 | Postoperative packing after septoplasty: is it necessary显示文摘 | Dubin M R Pletcher S D | 2009 | Otolaryngol Clin Noah Am2009，42，2： | 1 |
| 15 | A One step,solvother- mal reduction method for producing reduced graphene oxide dispersions in organic solvents 显示文摘 | S DUBIN S GILJE K WANG | 2010 | ACS Nano2010，4，7： | 1 |
| 16 | Comparative behavior of three wheat cultivars and their mixture in India, Nepal and Pakistan显示文摘 | Dubin H J Wolfe M S | 1994 | Field Crops Res1994，39，： | 1 |
| 17 | Laser scribing of high-performance and flexible graphene-based electrochemical capacitors显示文摘 | EI-KADY M F STRONG V DUBIN S | 2012 | Science2012，335，6074： | 1 |
| 18 | 人乳头瘤病毒16/18型AS04佐剂疫苗预防肿瘤基因型HPV引起的宫颈感染和癌前病变的效应(PATRICIA):一项在年轻女性中进行的双盲、随机研究的最终分析显示文摘背景在年轻成人中进行的Ⅲ期随机、双盲对照PATRICIA试验(PApilloma TRial)的事件驱动期中分析显示,人乳头瘤病毒(HPV)16/18AS04佐剂疫苗具有免疫原性,且总体耐受性良好,对HPV16或HPV18感染及相关的癌前病变具有预防效应。本文作者旨在评估最终事件驱动分析中的疫苗效应。方法将在基线、1个月和6个月接种疫苗的15~25岁女性分类为符合方案的效应队列(ATP-E队列;疫苗组8093例,对照组8069例)、总接种队列(TVC;包括至少接种1剂疫苗的所有女性,而不考虑其基线HPV状态;代表普遍的年轻女性人群,包括性活跃者;疫苗组9319例,对照组9325例)和TVC-naive(无证据表明基线时存在肿瘤基因型HPV感染;代表无性行为女性;疫苗组5822例,对照组5819例)。主要终点是。在基线时血清和DNA均为阴性且在6个月时为相应类型(ATP-E队列)的女性中,评估疫苗对HPV16或HPV18相关性宫颈上皮内瘤变≥2级(CIN2+)的预防效应。该试验在ClinicalTrial.gov上的注册编码为NCT00122681.结果第3剂疫苗接种后平均随访34.9个月(s=6.4)。在主要分析中疫苗对HPV16/18相关性CIN2+的预防效应为92.9%(96.1%CI79.9%~98.3%),在对可能因多种肿瘤基因型HPV引起的病变(ATP-E队列)的分析中,其预防效应为98.1%(96.1%CI88.4%~100%)。不考虑病变HPVDNA时,疫苗对CIN2+的预防效应在TVC中为30.4%(96.1%CI16.4%~42.1%),在TVC-naive中为70.2%(96.1%CI54.7%~80.9%);而对CIN3+的相应效应在TVC中为33.4%(96.1%CI9.1%~51.5%).在TVC-naive中为87.0%(96.1%CI54.9%~97.7%).在预防12种非疫苗肿瘤基因型HPv相关性CIN2+的效应为54.0%(96.1%CI34.0%~68.4%:ATP-E队列)。在TVC中可见对HPV31、33和45相关性CIN2+的个体交叉保护效应。结论HPV16/18 AS04佐剂疫苗表现出对HPV16/18和非疫苗肿瘤基因型HPV相关性CIN2+较强的预防效应,而要获得整体预防效应就需要在更广泛的人群中进行大面积强化免疫计划。基金 葛兰素史克。 | J Paavonen P Naud J Salmeron C M Wheeler S-N Chow D Apter H Kitchener X Castellsague J C Teixeira S R Skinner J Hedrick U Jaisamrarn G Limson S Garland A Szarewski B Romanowski F Y Aoki T F Schwarz W A J Poppe F X Bosch D Jenkins K Hardt T Zahaf D Descamps F Struyf M Lehtinen G Dubin 周彩虹(译) | 2009 | 世界临床医学2009，，12： | 1 |
| 19 | Ultrasonic thrombus disruption:in vitro study显示文摘 | Chae J S Dubin S B | 1990 | Am Heart J1990，120，2： | 1 |
| 20 | Secretion of lactoferrin and lysozyme by cultures of human airway epithelium显示文摘 | Dubin R F Robinson S K Widdicombe J H | 2004 | Am J Physiol Lung Cell Mol Physiol2004，286，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员